237 related articles for article (PubMed ID: 33544456)
1. Lipid emulsion therapy in women with recurrent pregnancy loss and repeated implantation failure: The role of abnormal natural killer cell activity.
Canella PRBC; Barini R; Carvalho PO; Razolli DS
J Cell Mol Med; 2021 Mar; 25(5):2290-2296. PubMed ID: 33544456
[TBL] [Abstract][Full Text] [Related]
2. Preimplantation factor inhibits circulating natural killer cell cytotoxicity and reduces CD69 expression: implications for recurrent pregnancy loss therapy.
Roussev RG; Dons'koi BV; Stamatkin C; Ramu S; Chernyshov VP; Coulam CB; Barnea ER
Reprod Biomed Online; 2013 Jan; 26(1):79-87. PubMed ID: 23186554
[TBL] [Abstract][Full Text] [Related]
3. Expression of natural cytotoxicity receptors and cytokine production on endometrial natural killer cells in women with recurrent pregnancy loss or implantation failure, and the expression of natural cytotoxicity receptors on peripheral blood natural killer cells in pregnant women with a history of recurrent pregnancy loss.
Fukui A; Funamizu A; Fukuhara R; Shibahara H
J Obstet Gynaecol Res; 2017 Nov; 43(11):1678-1686. PubMed ID: 28815854
[TBL] [Abstract][Full Text] [Related]
4. Functional NK surrogate biomarkers for inflammatory recurrent pregnancy loss and recurrent implantation failure.
Comins-Boo A; Cristóbal I; Fernández-Arquero M; Rodríguez de Frías E; Calvo Urrutia M; Pilar Suárez L; Gasca Escorial P; Ángel Herráiz M; Sánchez-Ramón S
Am J Reprod Immunol; 2021 Aug; 86(2):e13426. PubMed ID: 33811416
[TBL] [Abstract][Full Text] [Related]
5. Altered profile of plasma phospholipids in woman with recurrent pregnancy loss and recurrent implantation failure treated with lipid emulsion therapy.
Canella PRBC; Vinces SS; Silva ÁAR; Sanches PHG; Barini R; Porcari AM; Razolli DS; Carvalho PO
Am J Reprod Immunol; 2023 Mar; 89(3):e13673. PubMed ID: 36585861
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy to improve pregnancy outcome in women with abnormal natural killer cell levels/activity and recurrent miscarriage or implantation failure: A systematic review and meta-analysis.
Woon EV; Day A; Bracewell-Milnes T; Male V; Johnson M
J Reprod Immunol; 2020 Nov; 142():103189. PubMed ID: 32889304
[TBL] [Abstract][Full Text] [Related]
7. Intralipid treatment for women with reproductive failures.
Coulam CB
Am J Reprod Immunol; 2021 Apr; 85(4):e13290. PubMed ID: 32567756
[TBL] [Abstract][Full Text] [Related]
8. Uterine and circulating natural killer cells and their roles in women with recurrent pregnancy loss, implantation failure and preeclampsia.
Fukui A; Funamizu A; Yokota M; Yamada K; Nakamua R; Fukuhara R; Kimura H; Mizunuma H
J Reprod Immunol; 2011 Jun; 90(1):105-10. PubMed ID: 21632120
[TBL] [Abstract][Full Text] [Related]
9. Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure.
Sato T; Sugiura-Ogasawara M; Ozawa F; Yamamoto T; Kato T; Kurahashi H; Kuroda T; Aoyama N; Kato K; Kobayashi R; Fukuda A; Utsunomiya T; Kuwahara A; Saito H; Takeshita T; Irahara M
Hum Reprod; 2019 Dec; 34(12):2340-2348. PubMed ID: 31811307
[TBL] [Abstract][Full Text] [Related]
10. Placenta specific protein-1 in recurrent pregnancy loss and in
Yilmaz N; Timur H; Ugurlu EN; Yilmaz S; Ozgu-Erdinc AS; Erkilinc S; Inal HA
J Obstet Gynaecol; 2020 Aug; 40(6):843-848. PubMed ID: 31791163
[TBL] [Abstract][Full Text] [Related]
11. Post-hoc evaluation of peripheral blood natural killer cell cytotoxicity in predicting the risk of recurrent pregnancy losses and repeated implantation failures.
Salazar MD; Wang WJ; Skariah A; He Q; Field K; Nixon M; Reed R; Dambaeva S; Beaman K; Gilman-Sachs A; Kwak-Kim J
J Reprod Immunol; 2022 Mar; 150():103487. PubMed ID: 35078138
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of peripheral and uterine immune status of chronic endometritis in patients with recurrent reproductive failure.
Li Y; Yu S; Huang C; Lian R; Chen C; Liu S; Li L; Diao L; Markert UR; Zeng Y
Fertil Steril; 2020 Jan; 113(1):187-196.e1. PubMed ID: 31718829
[TBL] [Abstract][Full Text] [Related]
13. Where and when should natural killer cells be tested in women with repeated implantation failure?
Santillán I; Lozano I; Illán J; Verdú V; Coca S; Bajo-Arenas JM; Martinez F
J Reprod Immunol; 2015 Apr; 108():142-8. PubMed ID: 25708533
[TBL] [Abstract][Full Text] [Related]
14. Proportion of Cytotoxic Peripheral Blood Natural Killer Cells and T-Cell Large Granular Lymphocytes in Recurrent Miscarriage and Repeated Implantation Failure: Case-Control Study and Meta-analysis.
Kolanska K; Suner L; Cohen J; Ben Kraiem Y; Placais L; Fain O; Bornes M; Selleret L; Delhommeau F; Feger F; Mathieu d'Argent E; Darai E; Chabbert-Buffet N; Antoine JM; Kayem G; Mekinian A
Arch Immunol Ther Exp (Warsz); 2019 Aug; 67(4):225-236. PubMed ID: 31147723
[TBL] [Abstract][Full Text] [Related]
15. Correlation between natural cytotoxicity receptors and intracellular cytokine expression of peripheral blood NK cells in women with recurrent pregnancy losses and implantation failures.
Fukui A; Ntrivalas E; Fukuhara R; Fujii S; Mizunuma H; Gilman-Sachs A; Beaman K; Kwak-Kim J
Am J Reprod Immunol; 2009 Dec; 62(6):371-80. PubMed ID: 19821805
[TBL] [Abstract][Full Text] [Related]
16. Systemic Characterization of Novel Immune Cell Phenotypes in Recurrent Pregnancy Loss.
Liu H; Lin XX; Huang XB; Huang DH; Song S; Chen YJ; Tang J; Tao D; Yin ZN; Mor G; Liao AH
Front Immunol; 2021; 12():657552. PubMed ID: 34122414
[TBL] [Abstract][Full Text] [Related]
17. The Update Immune-Regulatory Role of Pro- and Anti-Inflammatory Cytokines in Recurrent Pregnancy Losses.
Yang X; Tian Y; Zheng L; Luu T; Kwak-Kim J
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613575
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis.
Seshadri S; Sunkara SK
Hum Reprod Update; 2014; 20(3):429-38. PubMed ID: 24285824
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood NK cell cytotoxicities are negatively correlated with CD8(+) T cells in fertile women but not in women with a history of recurrent pregnancy loss.
Yoo JH; Kwak-Kim J; Han AR; Ahn H; Cha SH; Koong MK; Kang IS; Yang KM
Am J Reprod Immunol; 2012 Jul; 68(1):38-46. PubMed ID: 22537159
[TBL] [Abstract][Full Text] [Related]
20. KIR, LILRB and their Ligands' Genes as Potential Biomarkers in Recurrent Implantation Failure.
Nowak I; Wilczyńska K; Wilczyński JR; Malinowski A; Radwan P; Radwan M; Kuśnierczyk P
Arch Immunol Ther Exp (Warsz); 2017 Oct; 65(5):391-399. PubMed ID: 28523429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
